Paul Schimmel, Director at aTYR PHARMA INC (ATYR), bought 141,052 shares at $1.74 ($256K) on 2024-07-22, disclosed to the SEC on 2024-07-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.74 | 41,052 | $71K | 27.9% |
| 2 | $1.74 | 41,052 | $71K | 27.9% |
| 3 | $1.82 | 6,648 | $12K | 4.7% |
| 4 | $1.93 | 52,300 | $101K | 39.4% |
| Total | $1.81 avg | 141,052 | $256K | 100% |
| Filing → |
| LIFE | BUY | 2023-05-11 | $450K | — | Filing → |
| LIFE | BUY | 2021-09-22 | $2.0M | — | Filing → |
| LIFE | BUY | 2021-05-20 | $199K | — | Filing → |